Bridgefront Capital, LLC Assembly Biosciences, Inc. Transaction History

Bridgefront Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.35 - $2.29 $13,684 - $23,213	-10,137 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.14 - $3.9 $4,289 - $5,327	-1,366 Reduced 11.88%	10,137 $35,000
Q2 2021 Aug 12, 2021	BUY	$3.8 - $4.56 $43,711 - $52,453	11,503 New	11,503 $45,000
Q1 2021 May 17, 2021	SELL	$4.33 - $6.63 $63,001 - $96,466	-14,550 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$4.87 - $17.29 $70,858 - $251,569	14,550 New	14,550 $88,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.